REFERENCES
- Rabe K F, Hurd S, Anzueto A, Barnes P J, Buist S A, Calverley P, et al. Global Strategy for the Diagnosis, Management, and Prevention of COPD – 2006 Update. Am J Respir Crit Care Med 2007; 176(6)532–555
- Hay J G, Stone P, Carter J, Church S, Eyre-Brook A, Pearson M G, et al. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J 1992; 5(6)659–664
- Cooper C B. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006; 119: 21–31, (10 Suppl 1)
- Dodd D S, Brancatisano T, Engel L A. Chest wall mechanics during exercise in patients with severe chronic air-flow obstruction. Am Rev Respir Dis 1984; 129(1)33–38
- O'Donnell D E, Lam M, Webb K A. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1557–1565, (5 Pt 1)
- O'Donnell D E, Webb K A. Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations. Chest 1992; 102(3)824–831
- Yan S, Kaminski D, Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156(1)55–59
- Gelb A F, Gutierrez C A, Weisman I M, Newsom R, Taylor C F, Zamel N. Simplified detection of dynamic hyperinflation. Chest 2004; 126(6)1855–1860
- Maltais F, Hamilton A, Marciniuk D, Hernandez P, Sciurba F C, Richter K, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 2005; 128(3)1168–1178
- O'Donnell D E, Lam M, Webb K A. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160(2)542–549
- O'Donnell D E, Voduc N, Fitzpatrick M, Webb K A. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004; 24(1)86–94
- Fujimoto K, Yoshiike F, Yasuo M, Kitaguchi Y, Urushihata K, Kubo K, et al. Effects of bronchodilators on dynamic hyperinflation following hyperventilation in patients with COPD. Respirology 2007; 12(1)93–99
- Celli B R, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23(6)932–946
- Miller M R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26(2)319–338
- O'Donnell D E, Revill S M, Webb K A. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164(5)770–777
- Gelb A F, Taylor C F, McClean P A, Shinar C M, Rodrigues M T, Gutierrez C A, et al. Tiotropium and simplified detection of dynamic hyperinflation. Chest 2007; 131(3)690–695
- Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 2003; 124(5)1743–1748
- Diaz O, Villafranca C, Ghezzo H, Borzone G, Leiva A, Milic-Emil J, et al. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J 2000; 16(2)269–275
- Belman M J, Botnick W C, Shin J W. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153(3)967–975
- Martinez F J, de Oca M M, Whyte R I, Stetz J, Gay S E, Celli B R. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med 1997; 155(6)1984–1990
- O'Donnell D E, D'Arsigny C, Webb K A. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163(4)892–898
- O'Donnell D E, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23(6)832–840
- Porszasz J, Emtner M, Goto S, Somfay A, Whipp B J, Casaburi R. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005; 128(4)2025–2034
- Somfay A, Porszasz J, Lee S M, Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J 2001; 18(1)77–84
- Bloch K E, Li Y, Zhang J, Bingisser R, Kaplan V, Weder W, et al. Effect of surgical lung volume reduction on breathing patterns in severe pulmonary emphysema. Am J Respir Crit Care Med 1997; 156: 553–560, (2 Pt 1)
- Clarenbach C F, Senn O, Brack T, Kohler M, Bloch K E. Monitoring of ventilation during exercise by a portable respiratory inductive plethysmograph. Chest 2005; 128(3)1282–1290